Literature DB >> 12611269

Aerosol gene therapy.

Ajay Gautam1, J Clifford Waldrep, Charles L Densmore.   

Abstract

Gene therapy is a novel field of medicine that holds tremendous therapeutic potential for a variety of human diseases. Targeting of therapeutic gene delivery vectors to the lungs can be beneficial for treatment of various pulmonary diseases such as lung cancer, cystic fibrosis, pulmonary hypertension, alpha-1 antitrypsin deficiency, and asthma. Inhalation therapy using formulations delivered as aerosols targets the lungs through the pulmonary airways. The instant access and the high ratio of the drug deposited within the lungs noninvasively are the major advantages of aerosol delivery over other routes of administration. Delivery of gene formulations via aerosols is a relatively new field, which is less than a decade old. However, in this short period of time significant developments in aerosol delivery systems and vectors have resulted in major advances toward potential applications for various pulmonary diseases. This article will review these advances and the potential future applications of aerosol gene therapy technology.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12611269     DOI: 10.1385/mb:23:1:51

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  40 in total

1.  Optimization of formulations and conditions for the aerosol delivery of functional cationic lipid:DNA complexes.

Authors:  S J Eastman; J D Tousignant; M J Lukason; H Murray; C S Siegel; P Constantino; D J Harris; S H Cheng; R K Scheule
Journal:  Hum Gene Ther       Date:  1997-02-10       Impact factor: 5.695

2.  Plasmid DNA molecules complexed with cationic liposomes are protected from degradation by nucleases and shearing by aerosolisation.

Authors:  K Crook; G McLachlan; B J Stevenson; D J Porteous
Journal:  Gene Ther       Date:  1996-09       Impact factor: 5.250

3.  Pulmonary cytokine responses associated with PEI-DNA aerosol gene therapy.

Authors:  A Gautam; C L Densmore; J C Waldrep
Journal:  Gene Ther       Date:  2001-02       Impact factor: 5.250

4.  No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes.

Authors:  A E Canonico; J D Plitman; J T Conary; B O Meyrick; K L Brigham
Journal:  J Appl Physiol (1985)       Date:  1994-07

5.  EGTA enhancement of adenovirus-mediated gene transfer to mouse tracheal epithelium in vivo.

Authors:  Q Chu; J A St George; M Lukason; S H Cheng; R K Scheule; S J Eastman
Journal:  Hum Gene Ther       Date:  2001-03-20       Impact factor: 5.695

6.  Aerosol administration of a recombinant adenovirus expressing CFTR to cystic fibrosis patients: a phase I clinical trial.

Authors:  G Bellon; L Michel-Calemard; D Thouvenot; V Jagneaux; F Poitevin; C Malcus; N Accart; M P Layani; M Aymard; H Bernon; J Bienvenu; M Courtney; G Döring; B Gilly; R Gilly; D Lamy; H Levrey; Y Morel; C Paulin; F Perraud; L Rodillon; C Sené; S So; F Touraine-Moulin; A Pavirani
Journal:  Hum Gene Ther       Date:  1997-01-01       Impact factor: 5.695

7.  Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung.

Authors:  R K Scheule; J A St George; R G Bagley; J Marshall; J M Kaplan; G Y Akita; K X Wang; E R Lee; D J Harris; C Jiang; N S Yew; A E Smith; S H Cheng
Journal:  Hum Gene Ther       Date:  1997-04-10       Impact factor: 5.695

8.  A concentrated and stable aerosol formulation of cationic lipid:DNA complexes giving high-level gene expression in mouse lung.

Authors:  S J Eastman; M J Lukason; J D Tousignant; H Murray; M D Lane; J A St George; G Y Akita; M Cherry; S H Cheng; R K Scheule
Journal:  Hum Gene Ther       Date:  1997-04-10       Impact factor: 5.695

9.  Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits.

Authors:  A E Canonico; J T Conary; B O Meyrick; K L Brigham
Journal:  Am J Respir Cell Mol Biol       Date:  1994-01       Impact factor: 6.914

10.  Non-invasive liposome-mediated gene delivery can correct the ion transport defect in cystic fibrosis mutant mice.

Authors:  E W Alton; P G Middleton; N J Caplen; S N Smith; D M Steel; F M Munkonge; P K Jeffery; D M Geddes; S L Hart; R Williamson
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

View more
  2 in total

Review 1.  Veterinary vaccine nanotechnology: pulmonary and nasal delivery in livestock animals.

Authors:  Daniella Calderon-Nieva; Kalhari Bandara Goonewardene; Susantha Gomis; Marianna Foldvari
Journal:  Drug Deliv Transl Res       Date:  2017-08       Impact factor: 4.617

2.  Poly(ester amine)-mediated, aerosol-delivered Akt1 small interfering RNA suppresses lung tumorigenesis.

Authors:  Cheng-Xiong Xu; Dhananjay Jere; Hua Jin; Seung-Hee Chang; Youn-Sun Chung; Ji-Young Shin; Ji-Eun Kim; Sung-Jin Park; Yong-Hoon Lee; Chan-Hee Chae; Kee Ho Lee; George R Beck; Chong-Su Cho; Myung-Haing Cho
Journal:  Am J Respir Crit Care Med       Date:  2008-02-28       Impact factor: 21.405

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.